Fol. Biol. 2018, 64, 71-83
https://doi.org/10.14712/fb2018064030071
The Role of HNF1B in Tumorigenesis of Solid Tumours: a Review of Current Knowledge
References
1. , S., Woolf, A. S., Johnstone, K. A., Wirsing, A., Harries, L. W., Long, D. A., Hennekam, R. C., Ledermann, S. E., Rees, L., van’t Hoff, W., Marks, S. D., Trompeter, R. S., Tullus, K., Winyard, P. J., Cansick, J., Mushtaq, I., Dhillon, H. K., Bingham, C., Edghill, E. L., Shroff, R., Stanescu, H., Ryffel, G. U., Ellard, S., Bockenhauer, D. (2009) HNF1B mutations associate with hypomagnesemia and renal magnesium wasting. J. Am. Soc. Nephrol. 20, 1123-1131.
<https://doi.org/10.1681/ASN.2008060633>
2. , M. I., Rodrigues, M., Lobo, L., Medeira, A., Sousa, A. B., Simao, C., Lemos, M. C. (2015) A novel mutation of the HNF1B gene associated with hypoplastic glomerulocystic kidney disease and neonatal renal failure: a case report and mutation update. Medicine (Baltimore) 94, e469.
<https://doi.org/10.1097/MD.0000000000000469>
3. , E., Chalkiadaki, A., Masdeu, C., Haumaitre, C., Lokmane, L., Loirat, C., Cloarec, S., Talianidis, I., Bellanne- Chantelot, C., Cereghini, S. (2004) HNF1β/TCF2 mutations impair transactivation potential through altered co-regulator recruitment. Hum. Mol. Genet. 13, 3139-3149.
<https://doi.org/10.1093/hmg/ddh338>
4. , C., Chauveau, D., Gautier, J. F., Dubois- Laforgue, D., Clauin, S., Beaufils, S., Wilhelm, J. M., Boitard, C., Noel, L. H., Velho, G., Timsit, J. (2004) Clinical spectrum associated with hepatocyte nuclear factor-1β mutations. Ann. Intern. Med. 140, 510-517.
<https://doi.org/10.7326/0003-4819-140-7-200404060-00009>
5. , S. I., Sampson, J., Yeager, M., Jacobs, K. B., Wang, Z., Hutchinson, A., Chung, C., Orr, N., Wacholder, S., Chatterjee, N., Yu, K., Kraft, P., Feigelson, H. S., Thun, M. J., Diver, W. R., Albanes, D., Virtamo, J., Weinstein, S., Schumacher, F. R., Cancel-Tassin, G., Cussenot, O., Valeri, A., Andriole, G. L., Crawford, E. D., Haiman, C., Henderson, B., Kolonel, L., Le Marchand, L., Siddiq, A., Riboli, E., Travis, R. C., Kaaks, R., Isaacs, W., Isaacs, S., Wiley, K. E., Gronberg, H., Wiklund, F., Stattin, P., Xu, J., Zheng, S. L., Sun, J., Vatten, L. J., Hveem, K., Njolstad, I., Gerhard, D. S., Tucker, M., Hayes, R. B., Hoover, R. N., Fraumeni, J. F., Jr., Hunter, D. J., Thomas, G., Chanock, S. J. (2011) Large-scale fine mapping of the HNF1B locus and prostate cancer risk. Hum. Mol. Genet. 20, 3322-3329.
<https://doi.org/10.1093/hmg/ddr213>
6. , D., Jaureguiberry, G. (2016) HNF1B-associated clinical phenotypes: the kidney and beyond. Pediatr. Nephrol. 31, 707-714.
<https://doi.org/10.1007/s00467-015-3142-2>
7. , I., Kovarikova, H., Laco, J., Ruszova, E., Dvorak, O., Palicka, V., Chmelarova, M. (2017) Next-generation sequencing approach in methylation analysis of HNF1B and GATA4 genes: searching for biomarkers in ovarian cancer. Int. J. Mol. Sci. 18, 474-485.
<https://doi.org/10.3390/ijms18020474>
8. , A., Castro, M., Hennig, A., Popp, T., Assmann, G., Stief, C. G., Zimmermann, W. (2010) Downregulation of HNF-1B in renal cell carcinoma is associated with tumor progression and poor prognosis. Urology 76, 507.e506-511.
<https://doi.org/10.1016/j.urology.2010.03.042>
9. , S. (1996) Liver-enriched transcription factors and hepatocyte differentiation. FASEB J. 10, 267-282.
<https://doi.org/10.1096/fasebj.10.2.8641560>
10. , G., Amankwah, E. K., Davis, S. N., Phelan, C. M., Park, J. Y., Pow-Sang, J., Kumar, N. B. (2013) Variation in HNF1B and obesity may influence prostate cancer risk in African American men: a pilot study. Prostate Cancer 2013, 384594.
<https://doi.org/10.1155/2013/384594>
11. , R. L., Hamilton, A. J., Hattersley, A. T., Ellard, S., Bingham, C. (2015) HNF1B-associated renal and extrarenal disease – an expanding clinical spectrum. Nat. Rev. Nephrol. 11, 102-112.
<https://doi.org/10.1038/nrneph.2014.232>
12. , E. A., Sadanandam, A., Olson, P., Gibb, W. J., Truitt, M., Gu, S., Cooc, J., Weinkle, J., Kim, G. E., Jakkula, L., Feiler, H. S., Ko, A. H., Olshen, A. B., Danenberg, K. L., Tempero, M. A., Spellman, P. T., Hanahan, D., Gray, J. W. (2011) Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat. Med. 17, 500-503.
<https://doi.org/10.1038/nm.2344>
13. , J., Salari, K., Clarke, N., Esheba, G. E., Forster, A. D., Huang, S., West, R. B., Higgins, J. P., Longacre, T. A., Pollack, J. R. (2013) Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis. PLoS One 8, e74562.
<https://doi.org/10.1371/journal.pone.0074562>
14. , A., Bluteau, O., Garcia-Gonzalez, M. A., Gresh, L., Doyen, A., Garbay, S., Robine, S., Pontoglio, M. (2010) Hepatocyte nuclear factor 1α and β control terminal differentiation and cell fate commitment in the gut epithelium. Development 137, 1573-1582.
<https://doi.org/10.1242/dev.044420>
15. , M. G., Kopp, J. L., Heliot, C., Sander, M., Cereghini, S., Haumaitre, C. (2015). Hnf1b controls pancreas morphogenesis and the generation of Ngn3+ endocrine progenitors. Development 142, 871-882.
<https://doi.org/10.1242/dev.110759>
16. , C., Godet, J., Pedretti, N., Bernard, F. X., Irani, J., Cathelineau, X., Cussenot, O., Fromont, G. (2014) Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression. Urol. Oncol. 32, 426-432.
<https://doi.org/10.1016/j.urolonc.2013.09.006>
17. , E. L., Bingham, C., Ellard, S., Hattersley, A. T. (2006) Mutations in hepatocyte nuclear factor-1β and their related phenotypes. J. Med. Genet. 43, 84-90.
<https://doi.org/10.1136/jmg.2005.032854>
18. , R., Vallier, L. (2016) The role of hepatocyte nuclear factor 1β in disease and development. Diabetes Obes. Metab. 18(Suppl 1), 23-32.
<https://doi.org/10.1111/dom.12715>
19. , K. S., Zeggini, E., McCarthy, M. I., Gudmundsson, J., Sulem, P., Stacey, S. N., Thorlacius, S., Amundadottir, L., Gronberg, H., Xu, J., Gaborieau, V., Eeles, R. A., Neal, D. E., Donovan, J. L., Hamdy, F. C., Muir, K., Hwang, S. J., Spitz, M. R., Zanke, B., Carvajal-Carmona, L., Brown, K. M., Australian Melanoma Family Study, I., Hayward, N. K., Macgregor, S., Tomlinson, I. P., Lemire, M., Amos, C. I., Murabito, J. M., Isaacs, W. B., Easton, D. F., Brennan, P., PanScan, C., Barkardottir, R. B., Gudbjartsson, D. F., Rafnar, T., Hunter, D. J., Chanock, S. J., Stefansson, K., Ioannidis, J. P. (2010) Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies. PLoS One 5, e10858.
<https://doi.org/10.1371/journal.pone.0010858>
20. , O., Liang, S. X. (2012) Diagnostic utility of hepatocyte nuclear factor 1β immunoreactivity in endometrial carcinomas: lack of specificity for endometrial clear cell carcinoma. Appl. Immunohistochem. Mol. Morphol. 20, 580-587.
<https://doi.org/10.1097/PAI.0b013e31824973d1>
21. , S. A., Beare, D., Gunasekaran, P., Leung, K., Bindal, N., Boutselakis, H., Ding, M., Bamford, S., Cole, C., Ward, S., Kok, C. Y., Jia, M., De, T., Teaque, J. W., Stratton, M. R., McDermott, U., Campbell, P. J. (2015) COSMIC: exploring the world’s knowledge of somatic mutations in human cancer. Nucleic Acids Res. 43, D805-811.
<https://doi.org/10.1093/nar/gku1075>
22. , G. V., Glinskii, A. B., Stephenson, A. J., Hoffman, R. M., Gerald, W. L. (2004) Gene expression profiling predicts clinical outcome of prostate cancer. J. Clin. Invest. 113, 913-923.
<https://doi.org/10.1172/JCI20032>
23. , C., Werner, L., Takeda, D., Awoyemi, B. C., Pomerantz, M. M., Yamada, H., Sooriakumaran, P., Robinson, B. D., Leung, R., Schinzel, A. C., Mills, I., Ross-Adams, H., Neal, D. E., Kido, M., Yamamoto, T., Petrozziello, G., Stack, E. C., Lis, R., Kantoff, P. W., Loda, M., Sartor, O., Egawa, S., Tewari, A. K., Hahn, W. C., Freedman, M. L. (2012) Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis. Proc. Natl. Acad. Sci. USA 109, 11252-11257.
<https://doi.org/10.1073/pnas.1200853109>
24. , I. S., Vesterhus, M., Raeder, H., Jensen, D. K., Sovik, O., Molven, A., Njolstad, P. R. (2008) Lack of pancreatic body and tail in HNF1B mutation carriers. Diabet. Med. 25, 782-787.
<https://doi.org/10.1111/j.1464-5491.2008.02460.x>
25. , L. W., Perry, J. R., McCullagh, P., Crundwell, M. (2010) Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer. BMC Cancer 10, 315.
<https://doi.org/10.1186/1471-2407-10-315>
26. , L. A., Gillanders, E. M., Manolio, T. A. (2011) Genetic architecture of cancer and other complex diseases: lessons learned and future directions. Carcinogenesis 32, 945-954.
<https://doi.org/10.1093/carcin/bgr056>
27. , Y. L., Zhong, D., Pang, F., Ning, Q. Y., Zhang, Y. Y., Li, G., Wu, J. Z., Mo, Z. N. (2013) HNF1B is involved in prostate cancer risk via modulating androgenic hormone effects and coordination with other genes. Genet. Mol. Res. 12, 1327-1335.
<https://doi.org/10.4238/2013.April.25.4>
28. , R., Binda, M. M., Allemeersch, J., Van den Broeck, A., Govaere, O., Swinnen, J. V., Roskams, T., Aerts, S., Topal, B. (2016) Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma. BMC Cancer 16, 632.
<https://doi.org/10.1186/s12885-016-2540-6>
29. , S. E., Kobel, M., Leung, S., Mehl, E., Gao, D., Marcon, K. M., Chow, C., Clarke, B. A., Huntsman, D. G., Gilks, C. B. (2011) Calculator for ovarian carcinoma subtype prediction. Mod. Pathol. 24, 512-521.
<https://doi.org/10.1038/modpathol.2010.215>
30. , N., Sasou, S., Motoyama, T. (2006) Expression of hepatocyte nuclear factor-1β (HNF-1β) in clear cell tumors and endometriosis of the ovary. Mod. Pathol. 19, 83-89.
<https://doi.org/10.1038/modpathol.3800492>
31. , N., Motoyama, T. (2009) Hepatocyte nuclear factor-1β (HNF-1β) in human urogenital organs: its expression and role in embryogenesis and tumorigenesis. Histol. Histopathol. 24, 1479-1486.
32. , S. L., McBride, H. A., Jamison, J., McCluggage, W. G. (2012) Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1β. Am. J. Surg. Pathol. 36, 799-807.
<https://doi.org/10.1097/PAS.0b013e31824a72c6>
33. , H. J., Bae, J. S., Lee, J., Chang, I. H., Kim, K. D., Shin, H. D., Han, J. H., Lee, S. Y., Kim, W., Myung, S. C. (2011) HNF1B polymorphism associated with development of prostate cancer in Korean patients. Urology 78, 969.e961-966.
34. , L. G., Chernov, I. P., Zinovyeva, M. V., Kopantzev, E. P., Sverdlov, E. D. (2017) Expression of master regulatory genes of embryonic development in pancreatic tumors. Dokl. Biochem. Biophys. 475, 250-252.
<https://doi.org/10.1134/S1607672917040020>
35. , G., Vasiliu, V., Bellanne-Chantelot, C., Bensman, A., Ulinski, T., Chretien, Y., Grunfeld, J. P. (2005) Cystic kidney disease, chromophobe renal cell carcinoma and TCF2 (HNF1β) mutations. Nat. Clin. Pract. Nephrol. 1, 115-119.
<https://doi.org/10.1038/ncpneph0054>
36. , J., Zhang, Y., Gao, Y., Cui, Y., Liu, H., Li, M., Tian, Y. (2014) Downregulation of HNF1 homeobox B is associated with drug resistance in ovarian cancer. Oncol. Rep. 32, 979-988.
<https://doi.org/10.3892/or.2014.3297>
37. , L., Haumaitre, C., Garcia-Villalba, P., Anselme, I., Schneider-Maunoury, S., Cereghini, S. (2008) Crucial role of vHNF1 in vertebrate hepatic specification. Development 135, 2777-2786.
<https://doi.org/10.1242/dev.023010>
38. , V. D., Farnetti, E., Torricelli, F., Abrate, M., Casali, B., Ciarlini, G., Pirillo, D., Gelli, M. C., Nicoli, D., Grassi, M., GB, L. A. S., Palomba, S. (2015) HNF1B polymorphism influences the prognosis of endometrial cancer patients: a cohort study. BMC Cancer 15, 229.
<https://doi.org/10.1186/s12885-015-1246-5>
39. , A., Fujimoto, J., Ishikawa, K., Ito, E., Goshima, N., Watanabe, S., Semba, K. (2016) Hepatocyte nuclear factor 1β induces transformation and epithelial-to-mesenchymal transition. FEBS Lett. 590, 1211-1221.
<https://doi.org/10.1002/1873-3468.12147>
40. , K., Cibula, D., Dundr, P. (2015a) Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases. Diagn. Pathol. 10, 8.
<https://doi.org/10.1186/s13000-015-0245-9>
41. , K., Kenny, S. L., Laco, J., Skapa, P., Stanek, L., Zikan, M., Kleiblova, P., McCluggage, W. G., Dundr, P. (2015b) Atypical polypoid adenomyoma of the uterus: an immunohistochemical and molecular study of 21 cases. Am. J. Surg. Pathol. 39, 1148-1155.
<https://doi.org/10.1097/PAS.0000000000000428>
42. , K., Ticha, I., Kleiblova, P., Bartu, M., Cibula, D., Jirsova, K., Dundr, P. (2016) Expression, epigenetic and genetic changes of HNF1B in endometrial lesions. Pathol. Oncol. Res. 22, 523-530.
<https://doi.org/10.1007/s12253-015-0037-2>
43. , H., Osame, K., Sasazuki, T., Noda, M. (2010) Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan. J. Diabetes Complications 24, 345-353.
<https://doi.org/10.1016/j.jdiacomp.2010.06.004>
44. , J. N., O’Mara, T. A., Batra, J., Cheng, T., Lose, F. A., Dennis, J., Michailidou, K., Tyrer, J. P., Ahmed, S., Ferguson, K., Healey, C. S., Kaufmann, S., Hillman, K. M., Walpole, C., Moya, L., Pollock, P., Jones, A., Howarth, K., Martin, L., Gorman, M., Hodgson, S., National Study of Endometrial Cancer Genetics, G., Consortium, C., De Polanco, M. M., Sans, M., Carracedo, A., Castellvi-Bel, S., Rojas-Martinez, A., Santos, E., Teixeira, M. R., Carvajal- Carmona, L., Shu, X. O., Long, J., Zheng, W., Xiang, Y. B., Australian National Endometrial Cancer Study, G., Montgomery, G. W., Webb, P. M., Scott, R. J., McEvoy, M., Attia, J., Holliday, E., Martin, N. G., Nyholt, D. R., Henders, A. K., Fasching, P. A., Hein, A., Beckmann, M. W., Renner, S. P., Dork, T., Hillemanns, P., Durst, M., Runnebaum, I., Lambrechts, D., Coenegrachts, L., Schrauwen, S., Amant, F., Winterhoff, B., Dowdy, S. C., Goode, E. L., Teoman, A., Salvesen, H. B., Trovik, J., Njolstad, T. S., Werner, H. M., Ashton, K., Proietto, T., Otton, G., Tzortzatos, G., Mints, M., Tham, E., Rendocas, Hall, P., Czene, K., Liu, J., Li, J., Hopper, J. L., Southey, M. C., Australian Ovarian Cancer, S., Ekici, A. B., Ruebner, M., Johnson, N., Peto, J., Burwinkel, B., Marme, F., Brenner, H., Dieffenbach, A. K., Meindl, A., Brauch, H., Network, G., Lindblom, A., Depreeuw, J., Moisse, M., Chang-Claude, J., Rudolph, A., Couch, F. J., Olson, J. E., Giles, G. G., Bruinsma, F., Cunningham, J. M., Fridley, B. L., Borresen-Dale, A. L., Kristensen, V. N., Cox, A., Swerdlow, A. J., Orr, N., Bolla, M. K., Wang, Q., Weber, R. P., Chen, Z., Shah, M., French, J. D., Pharoah, P. D., Dunning, A. M., Tomlinson, I., Easton, D. F., Edwards, S. L., Thompson, D. J., Spurdle, A. B. (2015) Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk. Hum. Mol. Genet. 24, 1478-1492.
<https://doi.org/10.1093/hmg/ddu552>
45. , K. J., Kiyokawa, T., Soslow, R. A., Lamb, C. A., Oliva, E., Zivanovic, O., Juretzka, M. M., Pirog, E. C. (2011) Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus. Am. J. Surg. Pathol. 35, 633-646.
<https://doi.org/10.1097/PAS.0b013e31821534b9>
46. , A. V., Rooman, I., Reichert, M., De Medts, N., Bouwens, L., Rustgi, A. K., Real, F. X. (2011) Adult pancreatic acinar cells dedifferentiate to an embryonic progenitor phenotype with concomitant activation of a senescence programme that is present in chronic pancreatitis. Gut 60, 958-966.
<https://doi.org/10.1136/gut.2010.225920>
47. , A. V., Pierreux, C. E., Lokmane, L., Haumaitre, C., Achouri, Y., Jacquemin, P., Rousseau, G. G., Cereghini, S., Lemaigre, F. P. (2006) A vHNF1/TCF2-HNF6 cascade regulates the transcription factor network that controls generation of pancreatic precursor cells. Diabetes 55, 61-69.
<https://doi.org/10.2337/diabetes.55.01.06.db05-0681>
48. , M. (2000) Hepatocyte nuclear factor 1, a transcription factor at the crossroads of glucose homeostasis. J. Am. Soc. Nephrol. 11(Suppl 16), S140-143.
<https://doi.org/10.1681/ASN.V11suppl_2s140>
49. , S., Vasiliu, V., Thomas, C., Bellanne-Chantelot, C., Bui, H., Chretien, Y., Timsit, J., Rosty, C., Laurent- Puig, P., Chauveau, D., Zucman-Rossi, J. (2005) Germline hepatocyte nuclear factor 1α and 1β mutations in renal cell carcinomas. Hum. Mol. Genet. 14, 603-614.
<https://doi.org/10.1093/hmg/ddi057>
50. , H., Ball, S., Lawrenson, K., Halim, S., Russell, R., Wells, C., Strand, S. H., Orntoft, T. F., Larson, M., Armasu, S., Massie, C. E., Asim, M., Mortensen, M. M., Borre, M., Woodfine, K., Warren, A. Y., Lamb, A. D., Kay, J., Whitaker, H., Ramos-Montoya, A., Murrell, A., Sorensen, K. D., Fridley, B. L., Goode, E. L., Gayther, S. A., Masters, J., Neal, D. E., Mills, I. G. (2016) HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer. Oncotarget 7, 74734-74746.
<https://doi.org/10.18632/oncotarget.12543>
51. , V. W., Haessler, J., Schumacher, F., Cote, M. L., Deelman, E., Fesinmeyer, M. D., Henderson, B. E., Jackson, R. D., Vockler, J. S., Wilkens, L. R., Yasmeen, S., Haiman, C. A., Peters, U., Le Marchand, L., Kooperberg, C. (2012) HNF1B and endometrial cancer risk: results from the PAGE study. PLoS One 7, e30390.
<https://doi.org/10.1371/journal.pone.0030390>
52. , H., Fridley, B. L., Song, H., Lawrenson, K., Cunningham, J. M., Ramus, S. J., Cicek, M. S., Tyrer, J., Stram, D., Larson, M. C., Kobel, M., Consortium, P., Ziogas, A., Zheng, W., Yang, H. P., Wu, A. H., Wozniak, E. L., Woo, Y. L., Winterhoff, B., Wik, E., Whittemore, A. S., Wentzensen, N., Weber, R. P., Vitonis, A. F., Vincent, D., Vierkant, R. A., Vergote, I., Van Den Berg, D., Van Altena, A. M., Tworoger, S. S., Thompson, P. J., Tessier, D. C., Terry, K. L., Teo, S. H., Templeman, C., Stram, D. O., Southey, M. C., Sieh, W., Siddiqui, N., Shvetsov, Y. B., Shu, X. O., Shridhar, V., Wang-Gohrke, S., Severi, G., Schwaab, I., Salvesen, H. B., Rzepecka, I. K., Runnebaum, I. B., Rossing, M. A., Rodriguez-Rodriguez, L., Risch, H. A., Renner, S. P., Poole, E. M., Pike, M. C., Phelan, C. M., Pelttari, L. M., Pejovic, T., Paul, J., Orlow, I., Omar, S. Z., Olson, S. H., Odunsi, K., Nickels, S., Nevanlinna, H., Ness, R. B., Narod, S. A., Nakanishi, T., Moysich, K. B., Monteiro, A. N., Moes-Sosnowska, J., Modugno, F., Menon, U., McLaughlin, J. R., McGuire, V., Matsuo, K., Adenan, N. A., Massuger, L. F., Lurie, G., Lundvall, L., Lubinski, J., Lissowska, J., Levine, D. A., Leminen, A., Lee, A. W., Le, N. D., Lambrechts, S., Lambrechts, D., Kupryjanczyk, J., Krakstad, C., Konecny, G. E., Kjaer, S. K., Kiemeney, L. A., Kelemen, L. E., Keeney, G. L., Karlan, B. Y., Karevan, R., Kalli, K. R., Kajiyama, H., Ji, B. T., Jensen, A., Jakubowska, A., Iversen, E., Hosono, S., Hogdall, C. K., Hogdall, E., Hoatlin, M., Hillemanns, P., Heitz, F., Hein, R., Harter, P., Halle, M. K., Hall, P., Gronwald, J., Gore, M., Goodman, M. T., Giles, G. G., Gentry-Maharaj, A., Garcia-Closas, M., Flanagan, J. M., Fasching, P. A., Ekici, A. B., Edwards, R., Eccles, D., Easton, D. F., Durst, M., du Bois, A., Dork, T., Doherty, J. A., Despierre, E., Dansonka- Mieszkowska, A., Cybulski, C., Cramer, D. W., Cook, L. S., Chen, X., Charbonneau, B., Chang-Claude, J., Campbell, I., Butzow, R., Bunker, C. H., Brueggmann, D., Brown, R., Brooks-Wilson, A., Brinton, L. A., Bogdanova, N., Block, M. S., Benjamin, E., Beesley, J., Beckmann, M. W., Bandera, E. V., Baglietto, L., Bacot, F., Armasu, S. M., Antonenkova, N., Anton-Culver, H., Aben, K. K., Liang, D., Wu, X., Lu, K., Hildebrandt, M. A., Australian Ovarian Cancer Study, G., Australian Cancer, S., Schildkraut, J. M., Sellers, T. A., Huntsman, D., Berchuck, A., Chenevix-Trench, G., Gayther, S. A., Pharoah, P. D., Laird, P. W., Goode, E. L., Pearce, C. L. (2013) Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat. Commun. 4, 1628.
<https://doi.org/10.1038/ncomms2629>
53. , H., Sudo, T., Shimada, K., Uekuri, C., Tsuji, Y., Kanayama, S., Naruse, K., Yamada, Y., Konishi, N., Kobayashi, H. (2014) Inhibition of cell death and induction of G2 arrest accumulation in human ovarian clear cells by HNF-1β transcription factor: chemosensitivity is regulated by checkpoint kinase CHK1. Int. J. Gynecol. Cancer 24, 838-843.
<https://doi.org/10.1097/IGC.0000000000000136>
54. , J. H., Lee, H. C., Han, S., Kang, H. J., Yu, E., Lee, S. G. (2013) Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays. Liver Transpl. 19, 336-345.
<https://doi.org/10.1002/lt.23584>
55. , T. D., Vidigal, V. M., Felipe, A. V., DE Lima, J. M., Neto, R. A., Saad, S. S., Forones, N. M. (2013) DNA methylation as an epigenetic biomarker in colorectal cancer. Oncol. Lett. 6, 1687-1692.
<https://doi.org/10.3892/ol.2013.1606>
56. , A. B., Thompson, D. J., Ahmed, S., Ferguson, K., Healey, C. S., O’Mara, T., Walker, L. C., Montgomery, S. B., Dermitzakis, E. T., Australian National Endometrial Cancer Study, G., Fahey, P., Montgomery, G. W., Webb, P. M., Fasching, P. A., Beckmann, M. W., Ekici, A. B., Hein, A., Lambrechts, D., Coenegrachts, L., Vergote, I., Amant, F., Salvesen, H. B., Trovik, J., Njolstad, T. S., Helland, H., Scott, R. J., Ashton, K., Proietto, T., Otton, G., National Study of Endometrial Cancer Genetics, G., Tomlinson, I., Gorman, M., Howarth, K., Hodgson, S., Garcia-Closas, M., Wentzensen, N., Yang, H., Chanock, S., Hall, P., Czene, K., Liu, J., Li, J., Shu, X. O., Zheng, W., Long, J., Xiang, Y. B., Shah, M., Morrison, J., Michailidou, K., Pharoah, P. D., Dunning, A. M., Easton, D. F. (2011) Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nat. Genet. 43, 451-454.
<https://doi.org/10.1038/ng.812>
57. , J., Zheng, S. L., Wiklund, F., Isaacs, S. D., Purcell, L. D., Gao, Z., Hsu, F. C., Kim, S. T., Liu, W., Zhu, Y., Stattin, P., Adami, H. O., Wiley, K. E., Dimitrov, L., Sun, J., Li, T., Turner, A. R., Adams, T. S., Adolfsson, J., Johansson, J. E., Lowey, J., Trock, B. J., Partin, A. W., Walsh, P. C., Trent, J. M., Duggan, D., Carpten, J., Chang, B. L., Gronberg, H., Isaacs, W. B., Xu, J. (2008) Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat. Genet. 40, 1153-1155.
<https://doi.org/10.1038/ng.214>
58. , E., Kajita, S., Takahashi, H., Matsumoto, T., Tsuruta, T., Saegusa, M. (2015) Transcriptional upregulation of HNF-1β by NF-κB in ovarian clear cell carcinoma modulates susceptibility to apoptosis through alteration in bcl-2 expression. Lab. Invest. 95, 962-972.
<https://doi.org/10.1038/labinvest.2015.73>
59. , A., Yusenko, M. V., Kuiper, R., van Kessel, A. G., Kovacs, G. (2011) Genomic profiling of papillary renal cell tumors identifies small regions of DNA alterations: a possible role of HNF1B in tumor development. Histopathology 58, 934-943.
<https://doi.org/10.1111/j.1365-2559.2011.03795.x>
60. , K., Toyota, M., Sagae, S., Ogi, K., Suzuki, H., Sonoda, T., Akino, K., Maruyama, R., Nishikawa, N., Imai, K., Shinomura, Y., Saito, T., Tokino, T. (2006) Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines. Br. J. Cancer 94, 914-921.
<https://doi.org/10.1038/sj.bjc.6602984>
61. , G., Jacobs, K. B., Yeager, M., Kraft, P., Wacholder, S., Orr, N., Yu, K., Chatterjee, N., Welch, R., Hutchinson, A., Crenshaw, A., Cancel-Tassin, G., Staats, B. J., Wang, Z., Gonzalez-Bosquet, J., Fang, J., Deng, X., Berndt, S. I., Calle, E. E., Feigelson, H. S., Thun, M. J., Rodriguez, C., Albanes, D., Virtamo, J., Weinstein, S., Schumacher, F. R., Giovannucci, E., Willett, W. C., Cussenot, O., Valeri, A., Andriole, G. L., Crawford, E. D., Tucker, M., Gerhard, D. S., Fraumeni, J. F., Jr., Hoover, R., Hayes, R. B., Hunter, D. J., Chanock, S. J. (2008) Multiple loci identified in a genome- wide association study of prostate cancer. Nat. Genet. 40, 310-315.
<https://doi.org/10.1038/ng.91>
62. , A., De Santis, G., Castellano, G., Miotti, S., Mazzi, M., Tomasoni, D., Van Roy, F., Carcangiu, M. L., Canevari, S. (2008) Variant HNF1 modulates epithelial plasticity of normal and transformed ovary cells. Neoplasia 10, 1481-1492.
<https://doi.org/10.1593/neo.81004>
63. , A., Sakamoto, M., Yasuda, J., Chuma, M., Ohta, T., Ohki, M., Yasugi, T., Taketani, Y., Hirohashi, S. (2003) Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1β as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma. Am. J. Pathol. 163, 2503-2512.
<https://doi.org/10.1016/S0002-9440(10)63605-X>
64. , J. C., Bech, A. P., Wetzels, J. F., Nijenhuis, T. (2016) Hepatocyte nuclear factor 1β-associated kidney disease: more than renal cysts and diabetes. J. Am. Soc. Nephrol. 27, 345-353.
<https://doi.org/10.1681/ASN.2015050544>
65. , S., Tsuda, H., Aida, S., Shimazaki, H., Tamai, S., Matsubara, O. (2007) Immunohistochemical detection of hepatocyte nuclear factor 1β in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometrium. Hum. Pathol. 38, 1074-1080.
<https://doi.org/10.1016/j.humpath.2006.12.018>
66. , S., Yang, J., You, Y., Cao, D., Huang, H., Wu, M., Chen, J., Lang, J., Shen, K. (2016) Clinicopathologic significance of HNF-1β, AIRD1A, and PIK3CA expression in ovarian clear cell carcinoma: a tissue microarray study of 130 cases. Medicine (Baltimore) 95, e3003.
<https://doi.org/10.1097/MD.0000000000003003>
67. , D. D., Jing, Y. Y., Guo, S. W., Ye, F., Lu, W., Li, Q., Dong, Y. L., Gao, L., Yang, Y. T., Yang, Y., Wu, M. C., Wei, L. X. (2015) Overexpression of hepatocyte nuclear factor-1β predicting poor prognosis is associated with biliary phenotype in patients with hepatocellular carcinoma. Sci. Rep. 5, 13319.
<https://doi.org/10.1038/srep13319>
68. , Y., Liang, J., Qi, J. G., Yang, N., Wu, G., Lin, Y. L., Cao, J. Y., Wang, Q., Wang, Q. C. (2015) Meta-analysis of the association between the HNF1B rs4430796 (A>G) polymorphism and risk of prostate cancer based on case-control studies. Genet. Mol. Res. 14, 7426-7435.
<https://doi.org/10.4238/2015.July.3.18>
